Medication-info.com Search Menu

Eskata (Hydrogen peroxide): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
40 mg/100 mg
Active ingredient:

Patient information: uses, side effects, how to take - Eskata

What is ESKATA ?

ESKATA is a prescription medicine used to treat seborrheic keratoses that are raised.

Before treatment with ESKATA, tell your healthcare provider about all of your medical conditions, including if you:

  • are being treated or have had treatments for seborrheic keratosis
  • have other skin problems
  • are pregnant or plan to become pregnant.

  • are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

How should I receive ESKATA ?

  • Your healthcare provider will apply ESKATA to your seborrheic keratosis lesions.
  • Your healthcare provider may apply ESKATA again, about 3 weeks after your treatment if your treated lesions are not completely gone.

What are the possible side effects with ESKATA?

ESKATA can cause serious side effects, including:

  • Eye problems. Eye problems can happen if ESKATA gets into your eyes, including:
  • ulcers or small holes in your eyes
  • scarring
  • redness
  • irritation
  • eyelid swelling
  • severe eye pain
  • permanent eye injury, including blindness

If ESKATA accidentally gets into your eyes, your healthcare provider will tell you to flush them well with water for 15 to 30 minutes. Your healthcare provider may send you to another healthcare care provider if needed.

  • Local skin reactions. Skin reactions have happened in and around the treatment area after application of ESKATA. Severe skin reactions can include: breakdown of the outer layer of the skin (erosion), ulcers, blisters and scarring. Tell your healthcare provider if you have any skin reactions during treatment with ESKATA.

The most common side effects of ESKATA include: itching, stinging, crusting, swelling, redness and scaling.

Your healthcare provider will not apply another treatment of ESKATA if your treated area is still irritated from the previous treatment.

Tell your healthcare provider right away if ESKATA gets into your eyes, mouth or nose during application.

These are not all of the possible side effects of ESKATA.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of ESKATA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your pharmacist or healthcare provider for information that is written for healthcare professionals.

What are the ingredients in ESKATA?

Active ingredient: hydrogen peroxide

Inactive ingredients: isopropyl alcohol and water.

Manufactured & Packaged by: James Alexander Corp., 845 Route 94, Blairstown, NJ 07825 United States

For: Aclaris Therapeutics, Inc., 640 Lee Rd, Suite 200, Wayne, PA 19087 United States

US Patent Number: US 7,381,427, US 9,675,639, US 9,980,983 and US 10,098,910

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 209305 · View the label on DailyMed

Revision date stated in the text: December 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Eskata

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Hydrogen peroxide 40 mg/100 mg
Dosage form Solution
Route Topical
Marketing status not in the current FDA NDC Directory
Company (applicant) ACLARIS
FDA approval NDA 209305New Drug Application (NDA) Approved December 14, 2017
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
40 mg/100 mg – 280 mg in 1 applicator / 1 in 1 carton NDC 71180-001-01
40 mg/100 mg – 280 mg in 1 applicator / 3 in 1 carton NDC 71180-001-03
40 mg/100 mg – 280 mg in 1 applicator / 12 in 1 carton NDC 71180-001-12
40 mg/100 mg – 520 mg in 1 applicator / 1 in 1 carton NDC 71180-002-01
40 mg/100 mg – 520 mg in 1 applicator / 3 in 1 carton NDC 71180-002-03
40 mg/100 mg – 520 mg in 1 applicator / 12 in 1 carton NDC 71180-002-12

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.